Aptose Biosciences (APTO) EGM 2024 summary

Opening remarks and agenda

• Meeting was properly constituted, with secretary and scrutineer appointed, and confirmation of notice and quorum established.

• Shareholders were reminded of their rights to address motions and the process for submitting questions.

Specific resolutions to be voted on

• Authorization sought for issuance of common shares underlying certain warrants, in compliance with Nasdaq Listing Rule 5635(d).

• Approval requested to adjourn the meeting if necessary to solicit additional proxies.

Shareholder proposals specific to EGM

• No additional proposals or other business were brought forward by shareholders or proxy holders.